Journal of the American Society of Echocardiography
Volume 21, Issue 1 , Pages 53-57 , January 2008

Safety and Predictors of Complications with a New Accelerated Dobutamine Stress Echocardiography Protocol

  • José Alberto San Román, MD, PhD, FESC

      Affiliations

    • Institute of Heart Sciences (ICICOR), Clinic University Hospital of Valladolid, Valladolid, Spain
    • Corresponding Author InformationReprint requests: José Alberto San Román, MD, PhD, FESC, Institute of Heart Sciences (ICICOR), Clinic University Hospital, C/Ramon y Cajal 3, 47005 Valladolid, Spain.
  • ,
  • Ricardo Sanz-Ruiz, MD

      Affiliations

    • Institute of Heart Sciences (ICICOR), Clinic University Hospital of Valladolid, Valladolid, Spain
  • ,
  • José Ramón Ortega, MD

      Affiliations

    • Cardiology Department, Dr. Negrín University Hospital of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
  • ,
  • Matías Pérez-Paredes, MD, PhD

      Affiliations

    • Cardiology Department, José M. Morales-Messeguer University Hospital of Murcia, Murcia, Spain
  • ,
  • María Jesús Rollán, MD, PhD

      Affiliations

    • Cardiology Department, Pío del Río Hortega University Hospital of Valladolid, Valladolid, Spain.
  • ,
  • Ana Cristina Muñoz, MD

      Affiliations

    • Cardiology Department, Pío del Río Hortega University Hospital of Valladolid, Valladolid, Spain.
  • ,
  • Federico Segura, MD

      Affiliations

    • Cardiology Department, Dr. Negrín University Hospital of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
  • ,
  • Diego Jimenez, MD, PhD

      Affiliations

    • Cardiology Department, José M. Morales-Messeguer University Hospital of Murcia, Murcia, Spain
  • ,
  • Andres Carnero, MD

      Affiliations

    • Cardiology Department, José M. Morales-Messeguer University Hospital of Murcia, Murcia, Spain
  • ,
  • Marta Pinedo, MD

      Affiliations

    • Institute of Heart Sciences (ICICOR), Clinic University Hospital of Valladolid, Valladolid, Spain
  • ,
  • Roman Arnold, MD

      Affiliations

    • Institute of Heart Sciences (ICICOR), Clinic University Hospital of Valladolid, Valladolid, Spain
  • ,
  • Itziar Gómez, MD

      Affiliations

    • Institute of Heart Sciences (ICICOR), Clinic University Hospital of Valladolid, Valladolid, Spain
  • ,
  • Francisco Fernández-Aviles, MD, PhD, FESC, FACC

      Affiliations

    • Institute of Heart Sciences (ICICOR), Clinic University Hospital of Valladolid, Valladolid, Spain

References 

  1. San Román JA, Vilacosta I, Castillo JA, Rollán MJ, Hernández M, Peral V, et al. Selection of the optimal stress test for the diagnosis of coronary artery disease. Heart. 1998;80:370–376
  2. San Román JA, Serrador A, Ortega JR, Medina A, Fernández-Aviléz F. Diagnostic accuracy of a new shorter dobutamine infusion protocol in stress echocardiography. Heart. 2003;89:1089–1090
  3. Dal Porto R, Faletra F, Picano E, Pirelli S, Moreo A, Varga A. Safety, feasibility, and diagnostic accuracy of accelerated high-dose dipyridamole stress echocardiography. Am J Cardiol. 2001;87:520–524
  4. San Román JA, Vilacosta I, Castillo JA, Rollán MJ, Peral V, Sánchez-Harquindey L, et al. Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease: comparison with exercise stress test, analysis of agreement, and impact of antianginal treatment. Chest. 1996;110:1248–1254
  5. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358–367
  6. Picano E, Mathias W, Pingitore A, Bigi R, Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study; echo dobutamine international cooperative study group. Lancet. 1994;344:1190–1192
  7. Secknus MA, Marwick TH. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years. J Am Coll Cardiol. 1997;29:1234–1240
  8. Mertes H, Sawada SG, Ryan T, Segar DS, Kovacs R, Foltz J, et al. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography: experience in 1,118 patients. Circulation. 1993;88:15–19
  9. Lu D, Greenberg MD, Little R, et al. Accelerated dobutamine stress testing: safety and feasibility in patients with known or suspected coronary artery disease. Clin Cardiol. 2001;24:141–145
  10. Burger AJ, Notarianni MP, Aronson D. Safety and efficacy of an accelerated dobutamine stress echocardiography protocol in the evaluation of coronary artery disease. Am J Cardiol. 2000;86:825–829
  11. Poldermans D, Fioretti PM, Boersma E, Forster T, van Urk H, Cornel JH, et al. Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. Am J Cardiol. 1994;73:456–459
  12. San Román JA, Vilacosta I, Rollán MJ, Castillo JA, Sánchez-Harquindey L, Fernández F. Impact of beta-blockers on dobutamine-atropine stress echocardiography. Echocardiography. 1996;13:373–380
  13. Varga A, Rodriguez MA, Picano E. Safety of stress echocardiography (from the international stress echo complication registry). Am J Cardiol. 2006;98:541–543

PII: S0894-7317(07)00396-3

doi: 10.1016/j.echo.2007.05.025

Journal of the American Society of Echocardiography
Volume 21, Issue 1 , Pages 53-57 , January 2008